9664 — Misonoza Theatrical Balance Sheet
0.000.00%
- ¥8bn
- ¥7bn
- ¥3bn
- 40
- 24
- 31
- 18
Annual balance sheet for Misonoza Theatrical, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 240 | 438 | 824 | 1,112 | 830 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 176 | 420 | 329 | 77.2 | 186 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 450 | 889 | 1,179 | 1,206 | 1,033 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,557 | 5,316 | 5,076 | 4,849 | 4,671 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,090 | 6,277 | 6,316 | 6,134 | 5,785 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 417 | 538 | 860 | 681 | 557 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,979 | 1,836 | 1,932 | 1,558 | 1,288 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 4,111 | 4,441 | 4,385 | 4,576 | 4,498 |
| Total Liabilities & Shareholders' Equity | 6,090 | 6,277 | 6,316 | 6,134 | 5,785 |
| Total Common Shares Outstanding |